Filing Details
- Accession Number:
- 0001104659-21-154012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-28 19:04:16
- Reporting Period:
- 2021-12-27
- Accepted Time:
- 2021-12-28 19:04:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1641640 | Nabriva Therapeutics Plc | NBRV | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1496194 | Christopher J. Naftzger | 414 Commerce Dr. Suite 120 Fort Washington PA 19034 | General Counsel And Corp Sec | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2021-12-27 | 7,000 | $0.59 | 7,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
